Abk�rzung zur Hauptnavigation Abk�rzung zu den Newsmeldungen Abk�rzung zu den Topstories  
  MedUni Vienna    Intranet    MedUni Vienna - Shop    University Library    University Hospital Vienna  
 
phd_neuroscience.png
 
 
 
Hauptnavigation
  • Home
  • General Informations
  • Research Laboratories
  • PhD Students
  • Lectures & Courses
 
PhD Neuroscience / Research Laboratories / Michael Freissmuth
 
Subnavigation
  • Igor Adameyko
  • Oskar Aszmann
  • Jan Bauer
  • Johannes Berger
  • Roland Beisteiner
  • Stefan Böhm
  • Roland Blumer
  • Monika Bradl
  • Hakan Cetin
  • Ruth Drdla-Schutting
  • Margot Ernst
  • Michael Freissmuth
  • Andreas Gruber
  • Andreas Hahn
  • Tibor Harkany
  • Ruth Herbst
  • Romana Höftberger
  • Thomas Klausberger
  • Helmut Kubista
  • Franco Laccone
  • Rupert Lanzenberger
  • Balint Lasztoczi
  • Ewald Moser
  • Vanja Nagy
  • Winfried Neuhaus
  • Daniela Pollak-Monje Quiroga
  • Andreas Pollreisz
  • Christine Radtke
  • Jürgen Sandkühler
  • Harald Sitte
  • Wolfgang M. Schmidt
  • Petra Scholze
  • Elisabeth Stögmann
  • Isabelle Weinhofer-Molisch
  • Isabella Wimmer
  • Lilli Winter
  • Fritz Zimprich
  • Alumni


Inhaltsbereich

Univ.Prof.Dr. Michael Freissmuth

Department(s): Institute of Pharmacology (Center for Physiology and Pharmacology)
Position: Professor
Location:
E-Mail:
Further information: http://www.meduniwien.ac.at/hp/zpp/institute-abteilungen/zentrum/

Research Interests:
Folding and targeting of neurotransmitter transporters and GPCRs, mechanism of drug action on GPCRs, Neurotransmitter Transporters, Signalling by G protein-coupled receptors (GPCRs)


Principle Investigator(s):

  • Freissmuth, Michael (Head)


Abstract:

Cells release diffusible signalling molecules, which engage GPCRs and which are in many instances cleared by reuptake via transporters. Both, GPCRs and neurotransmitter transporters are prime targets for drugs that act in the brain. As in business, location is key: the outcome of GPCR-dependent signalling is determined by the site, where the signal is generated. Accordingly, our current research focus is to understand how receptors and transporters reach their destination. In addition, we aim at translating our insights into therapeutic applications. This results in inductive leaps and surprising digressions into various areas including cancer models and haematopoetic stem cell transplantation.


Techniques:

Molecular pharmacology adapts the methodological repertoire of biochemistry and molecular biology to the study of drug action. In addition, we visualize the fate of our drug targets by fluorescence microscopy, their localization by confocal laser microscopy, their interaction with other proteins by fluorescence resonance energy transfer and their mobility by single particle tracking.


Selected Publications:

  1. Thurner P, Gsandtner I, Kudlacek O, Choquet D, Nanoff C, Freissmuth M, Zezula J (2014) A Two-state Model for the Diffusion of the A2A Adenosine Receptor in Hippocampal Neurons: AGONIST-INDUCED SWITCH TO SLOW MOBILITY IS MODIFIED BY SYNAPSE-ASSOCIATED PROTEIN 102 (SAP102) J Biol Chem, 289 (13): 9263-9274
  2. Montgomery T, Steinkellner T, Sucic S, Koban F, Schuchner S, Ogris E, Sitte H, Freissmuth M (2014) Axonal Targeting of the Serotonin Transporter in Cultured Rat Dorsal Raphe Neurons Is Specified by SEC24C-Dependent Export from the Endoplasmic Reticulum J Neurosci, 34 (18): 6344-6351
  3. Bergmayr C, Thurner P, Keuerleber S, Kudlacek O, Nanoff C, Freissmuth M, Gruber C (2013) Recruitment of a Cytoplasmic Chaperone Relay by the A2A Adenosine Receptor J Biol Chem, 288 (40): 28831-28844
  4. Sucic S, Koban F, El-Kasaby A, Kudlacek O, Stockner T, Sitte H, Freissmuth M (2013) Switching the Clientele: A LYSINE RESIDING IN THE C TERMINUS OF THE SEROTONIN TRANSPORTER SPECIFIES ITS PREFERENCE FOR THE COAT PROTEIN COMPLEX II COMPONENT SEC24C J Biol Chem, 288 (8): 5330-5341
  5. Keuerleber S, Thurner P, Gruber C, Zezula J, Freissmuth M (2012) Reengineering the Collision Coupling and Diffusion Mode of the A2A-adenosine Receptor: PALMITOYLATION IN HELIX 8 RELIEVES CONFINEMENT J Biol Chem, 287 (50): 42104-42118

Show all publications

 
Drucken
 
 
© MedUni Wien  | 
 Publishing information | Terms of use | Accessibility | Contact